Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0MSZBZ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
BB-1709
|
|||||
| Synonyms |
BB 1709; BB-1709; BB1709
Click to Show/Hide
|
|||||
| Organization |
Baili Sikang Biomedicine (Hangzhou) Co., Ltd.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
Undisclosed
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
5'-nucleotidase (NT5E)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Undisclosed
|
|||||
